Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 12

1.

Sex differences in pharmacokinetics and toxicity of antiretroviral therapy.

Umeh OC, Currier JS.

Expert Opin Drug Metab Toxicol. 2006 Apr;2(2):273-83. Review.

PMID:
16866613
[PubMed - indexed for MEDLINE]
2.

Gender differences in factors associated with adherence to antiretroviral therapy.

Berg KM, Demas PA, Howard AA, Schoenbaum EE, Gourevitch MN, Arnsten JH.

J Gen Intern Med. 2004 Nov;19(11):1111-7.

PMID:
15566440
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Gender differences and sex-specific manifestations associated with human immunodeficiency virus infection in women.

Gilad J, Walfisch A, Borer A, Schlaeffer F.

Eur J Obstet Gynecol Reprod Biol. 2003 Aug 15;109(2):199-205. Review.

PMID:
12860342
[PubMed - indexed for MEDLINE]
4.

Does patient sex affect human immunodeficiency virus levels?

Gandhi M, Bacchetti P, Miotti P, Quinn TC, Veronese F, Greenblatt RM.

Clin Infect Dis. 2002 Aug 1;35(3):313-22. Epub 2002 Jul 2. Erratum in: Clin Infect Dis 2002 Dec 1;35(11):1455.

PMID:
12115098
[PubMed - indexed for MEDLINE]
Free Article
5.

Interactions of the female hormonal environment, susceptibility to viral infections, and disease progression.

Brabin L.

AIDS Patient Care STDS. 2002 May;16(5):211-21. Review.

PMID:
12055029
[PubMed - indexed for MEDLINE]
6.

Role of nucleoside diphosphate kinase in the activation of anti-HIV nucleoside analogs.

Schneider B, Sarfati R, Deville-Bonne D, Véron M.

J Bioenerg Biomembr. 2000 Jun;32(3):317-24. Review.

PMID:
11768316
[PubMed - indexed for MEDLINE]
7.

Differential human immunodeficiency virus-suppressive activity of reverse transcription inhibitors in resting and activated peripheral blood lymphocytes: implications for therapy.

Davis C, Heredia A, Le N, Dominique JK, Redfield RR.

J Hum Virol. 2001 May-Jun;4(3):113-22.

PMID:
11572234
[PubMed - indexed for MEDLINE]
8.

Relative potency of protease inhibitors in monocytes/macrophages acutely and chronically infected with human immunodeficiency virus.

Perno CF, Newcomb FM, Davis DA, Aquaro S, Humphrey RW, Caliò R, Yarchoan R.

J Infect Dis. 1998 Aug;178(2):413-22.

PMID:
9697721
[PubMed - indexed for MEDLINE]
Free Article
10.

Initial studies on the cellular pharmacology of 3'-deoxythymidin-2'-ene (d4T): a potent and selective inhibitor of human immunodeficiency virus.

August EM, Marongiu ME, Lin TS, Prusoff WH.

Biochem Pharmacol. 1988 Dec 1;37(23):4419-22. No abstract available.

PMID:
2849444
[PubMed - indexed for MEDLINE]
11.

Cellular pharmacology of 2',3'-dideoxy-2',3'-didehydrothymidine, a nucleoside analog active against human immunodeficiency virus.

Ho HT, Hitchcock MJ.

Antimicrob Agents Chemother. 1989 Jun;33(6):844-9.

PMID:
2764535
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk